Founded in 2020, the goal of Sorbus Biomedical is to introduce innovative new biotech equipment that radically improves the function of cultivated cells, and subsequently the usefulness of cultured cells in Life Science and medical application.
Driven by earlier observations that traditional equipment have problematic limitations, Sorbus intends to induce a paradigm shift in how cultivated cells can be used in research and healthcare.
CEO and Founder Roger E. Rönn holds a PhD in human stem cell biology (Lund University), and has an extensive international track record in research and cell cultivation. After supplementing his scientific expertise with knowhow in both device prototyping and entrepreneurship, he founded Sorbus with the intention of making an impact to the field of Life Science.
Did you know?
Traditional cell cultivation in the lab exposes the cell to much higher levels of stress than what the cells would normally experience inside the body.